Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27166218 | 0.99 | KDM4E (0.38) | MEN1KMT2AFOLH1HRH1KDM4E | |
| SCHEMBL27166222 | 0.99 | KDM4E (0.38) | MEN1KMT2AFOLH1HRH1KDM4E | |
| SCHEMBL27166229 | 0.92 | KDM4E (0.40) | MEN1KMT2AFOLH1HRH1KDM4E | |
| SCHEMBL27166228 | 0.92 | FOLH1 (0.36) | MEN1KMT2AFOLH1KDM4EALDH1A1 | |
| SCHEMBL27166220 | 0.92 | FOLH1 (0.36) | MEN1KMT2AFOLH1KDM4EALDH1A1 | |
| SCHEMBL27166219 | 0.92 | MEN1 (0.46) | MEN1KMT2AFOLH1KDM4EALDH1A1 | |
| SCHEMBL27166254 | 0.91 | KDM4E (0.41) | MEN1KMT2AFOLH1HRH1KDM4E | |
| SCHEMBL27165218 | 0.91 | ALDH1A1 (0.43) | MEN1KMT2AFOLH1KDM4EALDH1A1 | |
| SCHEMBL27166241 | 0.91 | KDM4E (0.41) | MEN1KMT2AFOLH1HRH1KDM4E | |
| SCHEMBL27166221 | 0.91 | ALDH1A1 (0.43) | MEN1KMT2AFOLH1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4567716-B1 | GENERATING SYNTHETIC REPRESENTATIONS | BAYER AG (DE) | 2026-05-13 | — | — | EP | claimed |
| EP-4567715-B1 | GENERATING SYNTHETIC REPRESENTATIONS | BAYER AG (DE) | 2026-05-13 | — | — | EP | claimed |
| EP-4581641-B1 | GENERATION OF SYNTHETIC RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4581640-B1 | GENERATION OF SYNTHETIC RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4485474-B1 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2026-04-08 | — | — | EP | claimed |
| US-20260051027-A1 | GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES | BAYER AG (DE) | 2026-02-19 | — | — | US | claimed |
| EP-4664393-A1 | GENERATION OF SYNTHETIC CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | Bayer Aktiengesellschaft (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4475137-B1 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2025-12-03 | — | — | EP | claimed |
| EP-4567715-A1 | GENERATING SYNTHETIC REPRESENTATIONS | Bayer Aktiengesellschaft (DE) | 2025-06-11 | — | — | EP | claimed |
| EP-4498324-A1 | DETECTING ARTIFACTS IN SYNTHETIC IMAGES | Bayer AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4485474-A2 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | Bayer AG (DE) | 2025-01-01 | — | — | EP | claimed |
| EP-4475137-A1 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | Bayer AG (DE) | 2024-12-11 | — | — | EP | claimed |
| WO-2024100233-A1 | GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-16 | — | — | WO | claimed |
| WO-2024052156-A1 | GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | claimed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | claimed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | claimed |
| WO-2024046832-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | claimed |
| WO-2024046831-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | claimed |
| WO-2024046833-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | claimed |
| EP-4567716-B1 | GENERATING SYNTHETIC REPRESENTATIONS | BAYER AG (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4567715-B1 | GENERATING SYNTHETIC REPRESENTATIONS | BAYER AG (DE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4581641-B1 | GENERATION OF SYNTHETIC RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4581640-B1 | GENERATION OF SYNTHETIC RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4485474-B1 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-20260051027-A1 | GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES | BAYER AG (DE) | 2026-02-19 | — | — | US | disclosed |
| EP-4664393-A1 | GENERATION OF SYNTHETIC CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | Bayer Aktiengesellschaft (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4475137-B1 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | BAYER AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4567716-A1 | GENERATING SYNTHETIC REPRESENTATIONS | Bayer Aktiengesellschaft (DE) | 2025-06-11 | — | — | EP | disclosed |
| EP-4567715-A1 | GENERATING SYNTHETIC REPRESENTATIONS | Bayer Aktiengesellschaft (DE) | 2025-06-11 | — | — | EP | disclosed |
| EP-4498324-A1 | DETECTING ARTIFACTS IN SYNTHETIC IMAGES | Bayer AG (DE) | 2025-01-29 | — | — | EP | disclosed |
| EP-4485474-A2 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | Bayer AG (DE) | 2025-01-01 | — | — | EP | disclosed |
| EP-4475137-A1 | GENERATION OF ARTIFICIAL CONTRAST ENHANCED RADIOLOGICAL RECORDINGS | Bayer AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| EP-4375919-A1 | GENERATION OF CONTRAST ENHANCED SYNTHETIC RADIOLOGICAL RECORDINGS | Bayer AG (DE) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024100233-A1 | GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-05-16 | — | — | WO | disclosed |
| EP-4369353-A1 | GENERATION OF ARTIFICIAL CONTRAST AGENT-ENHANCED RADIOLOGICAL RECORDINGS | Bayer Aktiengesellschaft (DE) | 2024-05-15 | — | — | EP | disclosed |
| WO-2024083466-A1 | AUTOMATED ANALYSIS OF RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024052573-A1 | COMBINATIONS OF CONTRAST AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052156-A1 | GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | disclosed |
| EP-4335461-A1 | COMBINATIONS OF CONTRAST AGENTS | Bayer AG (DE) | 2024-03-13 | — | — | EP | disclosed |
| WO-2024046832-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024046832-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024046831-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024046833-A1 | GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260051027-A1 | GENERATION OF SYNTHETIC CONTRAST-ENHANCED RADIOLOGICAL IMAGES | WFS1, RXFP4, SLC11A2 | MEN1 994/4885KMT2A 2963/4885FOLH1 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.